Related Experiment Video
Updated: Mar 20, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Where does current and future pediatric asthma treatment stand? Remodeling and inflammation: Bird's eye view
1Department of Pediatric Allergy and Pulmonology, Celal Bayar University Medical Faculty, Manisa, Turkey.
Insights
Pediatric asthma involves airway remodeling due to inflammation. This review examines current and future therapies to interrupt this process in children, highlighting the need for personalized treatment approaches.
Area of Science:
- Pediatric Pulmonology
- Asthma Research
- Inflammation and Remodeling
Background:
- Airway remodeling is a chronic consequence of asthma-related inflammation.
- The transition from pediatric to adult age presents a critical window for intervention.
- Understanding pediatric asthma is key to interrupting airway remodeling.
Purpose of the Study:
- To review the impact of current and emerging therapies on airway inflammation and remodeling in pediatric asthma.
- To address the heterogeneity in research findings by considering individual pathogenetic characteristics.
- To emphasize the need for individualized treatment strategies in pediatric asthma management.
Main Methods:
- Systematic review of experimental and clinical research.
- Assessment of current therapeutic modalities for asthma.
- Evaluation of newly developed therapeutic agents.
Main Results:
- Varied results in studies suggest heterogeneous pathogenesis of asthma and remodeling.
- Current therapies show potential but require tailored application.
- New agents demonstrate promising outcomes for managing pediatric asthma.
Conclusions:
- Individualized treatment is crucial due to the diverse nature of pediatric asthma.
- Therapeutic strategies must target both inflammation and airway remodeling.
- Further research into novel agents and personalized approaches is warranted.
Abstract:
Airway remodeling is the chronic outcome of inflammation in asthma and a point of intervention between pediatric and adult ages. Pediatric asthma has been of great interest in the efforts to find a valuable time to interrupt remodeling. Various experimental and clinical research have assessed the effect of current therapeutic modalities on airway remodeling in asthma and many new agents are being developed with promising results. The heterogeneity in the results of these studies may lie in the heterogeneity of pathogenesis leading to asthma and remodeling; underlying the need for individualized treatment of the unique pathogenetic characteristics of each child's asthma. The aim of this review is to summarize the evidence about the influence of current and future therapeutic modalities in the concept of inflammation and remodeling in pediatric asthma. Pediatr Pulmonol. 2016;51:1422-1429. © 2016 Wiley Periodicals, Inc.
Related Concept Videos
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Asthma-IV: Nursing Management
First, in...

